Drug interactions
Betrixaban + Netupitant-palonosetron
Severity: Moderate
Betrixaban and Netupitant-palonosetron: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Betrixaban is a P-glycoprotein substrate, and inhibition of P-gp can raise its exposure and bleeding risk. Netupitant has some P-gp inhibitory activity, so concurrent use may increase anticoagulant effect.
What this interaction means in plain words
Betrixaban and Netupitant-palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Inhibition of P-glycoprotein efflux of betrixaban, increasing its absorption and reducing elimination.
What to do
Reduce betrixaban to the labeled dose for P-gp inhibitors (80 mg once, then 40 mg daily) and watch for bleeding.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Betrixaban and Netupitant-palonosetron, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Netupitant-palonosetron
- Apomorphine + Netupitant-palonosetron Contraindicated
- Flibanserin + Netupitant-palonosetron Contraindicated
- Apalutamide + Netupitant-palonosetron Major
- Avapritinib + Netupitant-palonosetron Major
- Carbamazepine + Netupitant-palonosetron Major
- Cobimetinib + Netupitant-palonosetron Major
Frequently asked questions
Can I take Betrixaban with Netupitant-palonosetron?
MediHelp rates the interaction as moderate. Betrixaban and Netupitant-palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Betrixaban is a P-glycoprotein substrate, and inhibition of P-gp can raise its exposure and bleeding risk. Netupitant has some P-gp inhibitory activity, so concurrent use may increase anticoagulant effect.
How serious is the interaction between Betrixaban and Netupitant-palonosetron?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce betrixaban to the labeled dose for P-gp inhibitors (80 mg once, then 40 mg daily) and watch for bleeding.
What other medicines interact with Netupitant-palonosetron?
MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.